Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03639623
- Locations
- ๐บ๐ธ
Virginia Commonwealth University, Richmond, Virginia, United States
Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII)
- Conditions
- Interventions
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT03617263
- Locations
- ๐บ๐ธ
Zydus US002, San Francisco, California, United States
๐บ๐ธZydus US008, Aurora, Colorado, United States
๐บ๐ธZydus US005, Chandler, Arizona, United States
Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis
- Conditions
- Interventions
- First Posted Date
- 2017-04-13
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT03112681
- Locations
- ๐บ๐ธ
California Liver Research Institute, Pasadena, California, United States
๐บ๐ธCarolinas Healthcare System, Charlotte, North Carolina, United States
๐บ๐ธSchiff Center for Liver Diseases/University of Miami, Miami, Florida, United States
Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride โฅ500 mg/dL and โค1500 mg/dL
- Conditions
- Interventions
- First Posted Date
- 2017-03-31
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 124
- Registration Number
- NCT03097107
- Locations
- ๐บ๐ธ
Herman Clinical Research, LLC, Suwanee, Georgia, United States
๐บ๐ธDrug Studies America, Marietta, Georgia, United States
๐บ๐ธRiver Birch Research Alliance LLC, Blue Ridge, Georgia, United States
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 106
- Registration Number
- NCT03061721
- Locations
- ๐บ๐ธ
Precision Research, San Diego, California, United States
๐บ๐ธCedars-Sinai Medical Center, Los Angeles, California, United States
๐บ๐ธCatalina Research Institute, Montclair, California, United States